The use of commercial fibrin glue in dermal replacement material reduces angiogenic and lymphangiogenic gene and protein expression in vitro

BACKGROUND: Commercial fibrin glue is increasingly finding its way into clinical practice in surgeries to seal anastomosis, and initiate hemostasis or tissue repair. Human biological glue is also being discussed as a possible cell carrier. To date, there are only a few studies addressing the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Benedikt, Birt, Alexandra, Moellhoff, Nicholas, Kuhlmann, Constanze, Giunta, Riccardo, Wiggenhauser, Paul Severin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Soft Tissues and Materials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226008/
https://www.ncbi.nlm.nih.gov/pubmed/37082911
http://dx.doi.org/10.1177/08853282231171681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226008/
https://www.ncbi.nlm.nih.gov/pubmed/37082911
http://dx.doi.org/10.1177/08853282231171681

Ejemplares similares